ClinicalTrials.Veeva

Menu

Is There is a Role of Prophylactic Therapy With Tamsulosin Before Extracorporeal Shock Wave Lithotripsy to Avoid Development of Steinstrasse ?

H

HaEmek Medical Center, Israel

Status

Unknown

Conditions

Kidney Stones

Treatments

Drug: tamsulosin 0.4mg

Study type

Observational

Funder types

Other

Identifiers

NCT00489723
0056-07-EMC

Details and patient eligibility

About

The purpose of this study is to determine if there is a role of prophylactic therapy with tamsulosin prior extracorporeal shock wave lithotripsy to avoid development of steinstrasse. 150 persons that will go to Extracorporeal shock wave lithotripsy will randomize to 2 groups.

Group 1 -of 75 persons will recieve tamsulosin 0.4 mg x 1/d 2 days before the lithotripsy .

Group 2 - of 75 persons will not recieve tamsulosin. 48 hour after the ESWL all 2 group will take abdominal radiograph to evaluate the presence of steinstrasse.

Sex

All

Ages

15 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • size of stone 1-2 cm

Exclusion criteria

  • ureteral stricture Presence of internal stent prior use of alfa bloker prior ESWL

Trial contacts and locations

1

Loading...

Central trial contact

DORON PEREZ, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems